The significantly lower risk associations of semaglutide with both incident and recurrent AUD persisted, though slightly attenuated with overlapping confidence intervals, for the 2-year and 3-year follow-up (Fig
Here are all the things I've noticed
Catch up on demand across three sessions and hear how AF management is changing Link in comments The first session on 'Breaking Barriers in Persistent AF: Delivering Results That Last' highlights what matters most for long-term success by exploring the latest data, including insights from the ADVANTAGE study Dr Andreas Metzner and Dr Joaquin Osca Asensi also guide a live case, showing how experts in leading centres apply these findings to refine their practice and provide real-world insight
However, semaglutide is not recommended for patients with a known history of pancreatitis
Pancreatic Cancer Semaglutide, the active ingredient in Ozempic, works as a GLP-1 receptor agonist
This is the most common symptom in individuals who are on semaglutide